Sana Biotechnology

IPO

Engineered cells as medicines

Public · Seattle, United States · Founded 2018 · $1.4B raised

Employees
201–500
Founded
2018
Business Model
B2B
Website
sana.com
Total Funding
$1.4B
Last Round
$821.0M Series DJun 2020
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sana Biotechnology is focused on creating engineered cells as medicines to repair and control genes or replace damaged cells, targeting diseases like diabetes, B-cell cancers, and autoimmune disorders. With operations in Seattle, Cambridge, and South San Francisco, Sana leverages expertise in cell and gene therapy to develop curative therapies.

Summary

Sana Biotechnology is a Biotech company based in Seattle, United States, founded in 2018. It has raised $1.4B in total across 5 rounds, most recently a $821.0M Series D round in Jun 2020. Investors include ARCH Venture Partners, Flagship Pioneering and SoftBank.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOFeb 2021
$587.5M

Sign up to see all 6 events

Funding: Seed through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sana Biotechnology on Indexed.vc
<a href="https://indexed.vc/companies/sana-biotechnology"><img src="https://indexed.vc/api/badge/company/sana-biotechnology" alt="Sana Biotechnology on Indexed.vc" width="260" height="76" /></a>